Kagami Yoshitoyo | Department Of Pathology School Of Medicine Kurume University
スポンサーリンク
概要
関連著者
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Seto M
Department Of Hematology And Chemotherapy
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
KOBAYASHI Yukio
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
Tobinai Kensei
東海大学 医学部
-
WATANABE Takashi
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Maruyama Dai
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
KODERA Yoshihisa
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
OHNO Ryuzo
Aichi Cancer Center
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
TAJI Hirofumi
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
KIM Sung-Won
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
Nakamura S
Department Of Pathology Nagoya University School Of Medicine
-
Nakamura Shigeo
国立がんセンター中央病院 血液内科
-
OHSHIMA Koichi
Department of Pathology, Kurume University School of Medicine
-
Sao Hiroshi
Department of Hematology, Meitetsu Hospital
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
KOJIMA Masaru
Department of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine
-
YOSHINO Tadashi
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutica
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
TAKEUCHI Jin
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
Iida Hiroatsu
Department of Hematology, Meitetsu Hospital
-
Mizuno Kyoichi
日本医科大学 内科学
-
谷脇 雅文
高知工科大学工学部
-
MIYAMURA Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
MIYAGI MAESHIMA
Clinical Laboratory, National Cancer Center Hospital
-
YOKOYAMA Hiroki
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
KOHNO Akio
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
Onishi Yasushi
Department Of Biostatistics School Of Public Health University Of Tokyo
-
Ichimiya Hitoshi
Division Of Surgery Hamanomachi General Hospital
-
Ito Hidemi
愛知県がんセンター研究所 疫学･予防部
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
KIYOI Hitoshi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Kamiya Yoshikazu
Department of Hematology, Meitetsu Hospital
-
SUGITA Yasuo
Department of Pathology and Biodefense, Saga University, Faculty of Medicine
-
Kato Harumi
Department of Cardiology, Kurashiki Central Hospital
-
MURAYAMA Tohru
Department of Hematology, Hyogo Medical Center for Adults
-
NOMOTO Junko
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
YOSHIDA Shiro
Department of Obstetrics, Center for Perinatal Medicine
-
Yoshida Shiro
Department Of Obstetrics Center For Perinatal Medicine
-
Sadahira Yoshito
Department Of Pathology School Of Medicine Kurume University
-
Horlad Hasita
Department Of Gastroenterological Surgery Graduate School Of Medical Sciences Kumamoto University
-
MORISHITA Yoshihisa
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
SAWA Masashi
Department of Hematology, Anjo Kosei Hospital
-
CHOU Takaaki
Department of Internal Medicine, Niigata Cancer Center Hospital
-
Ueda R
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
Seto M
Aichi Cancer Center Res. Inst. Nagoya
-
Ito H
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
MATSUO Keitaro
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
KISHIMOTO Yuji
The First Department of Internal Medicine, Kansai Medical University
-
TAKAHASHI Masatomo
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School
-
MITANI Kinuko
Department of Hematology, Dokkyo University School of Medicine
-
MIYAZAKI Yasushi
The Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine
-
OGAWA Yoshiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
KATO Shunichi
Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine
-
永井 正
自治医科大学内科学講座血液学部門
-
Mizuno Kyoichi
Division Of Cardiology Hepatology Geriatrics And Integrated Medicine Department Of Internal Medicine
-
Matsuda Koichi
Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
喜多 義邦
Division Of Preventive Cardiology National Cardiovascular Center
-
Takeya Motohiro
Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University
-
Tatematsu M
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
TANIGUCHI Hirokazu
Clinical Laboratory, National Cancer Center Hospital
-
MATSUNO Yoshihiro
Department of Surgical Pathology, Hokkaido University Hospital
-
YAMASAKI Satoshi
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
NAKATA Masanobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Mizuno Kyoichi
First Department Of Internal Medicine Nippon Medical School
-
Hirose Shinichi
Department of Pediatrics, Faculty of Medicine, Fukuoka University
-
TSUCHIDA Masahiro
Department of Pediatrics, Ibaraki Children's Hospital
-
Takagi K
Department Of Medical Technology Nagoya University School Of Health Sciences
-
YAMAMURA Yoshitaka
Department of Gastroenterological Surgery, Aichi Cancer Center Hospital
-
Hisamichi S
Tohoku University 21st Century Coe Program 'comprehensive Research And Education Center For Pla
-
Shiba T
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Totsune Kazuhito
東北大学 臨床薬学
-
Tokunaga Katsushi
Department Of Clinical Pharmacology And Therapeutics Tohoku University Graduate School Of Pharmaceut
-
TAKAGI Tadayuki
Department of Internal Medicine 2, Fukushima Medical University School of Medicine
-
Kondo Takaaki
Department Of Cardiology Nagoya University Graduate School Of Medicine
-
Tomoike Hitonobu
国立循環器病センター 疫学部
-
Tomoike Hitonobu
国立循環器病センター研究所 疫学部
-
TERAKURA Seitaro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
ASANO Naoko
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
永井 正
自治医科大学 内科学講座血液学部門
-
橋本 周司
早稲田大学理工学術院先進理工学研究科
-
Hashimoto S
Department Of Hygiene Fujita Health University School Of Medicine
-
USUI Noriko
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
MITSUDOMI Tetsuya
Department of Thoracic Surgery, Aichi Cancer Center Central Hospital
-
Honda Sumihisa
Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences
-
UEDA Ryuzo
Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sci
-
NAGAI Tadashi
Division of Hematology, Jichi Medical University
-
OKADA Masaya
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine
-
HANDA Hiroshi
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
-
KAGEYAMA Shinichi
Department of Hematology and Oncology, Mie University Graduate School of Medicine
-
MAEDA Yasuhiro
Department of Hematology, Kinki University School of Medicine
-
OHNISHI Kazunori
Oncology Center, Hamamatsu University School of Medicine
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
GONDO Hisashi
Department of Internal Medicine, Saga Prefectural Hospital Koseikan
-
SAKAMAKI Hisashi
Division of Hematology, Tokyo Metropolitan Komagome Hospital
-
佐々木 毅
東北大学大学院医学系研究科医科学専攻病態制御学講座免疫・血液病制御学分野
-
ISHIKAWA Yuichi
Department of Pathology, the Cancer Institute of JFCR
-
ANDO Kiyoshi
Department of Hematology/Oncology, Tokai University School of Medicine
-
佐々木 毅
東北大 院 医 分子診断学 免疫血液病制御
-
TAMAKOSHI Akiko
Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Gradu
-
KUSHIRO Toshio
Nihon University
-
馬場 秀夫
国立病院機構熊本南病院 外科
-
Suzuki Tatsuya
Department Of Obstetrics And Gynecology School Of Medicine Jichi Medical University
-
Tateno Masatoshi
Department of Pathology, Sapporo City General Hospital
-
Sasaki Takeshi
Department of Rheumatology, Tohoku University school of Medicine
-
Sakashita Naomi
Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University
-
TAKAMI Akiyoshi
Department of Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine
-
KAMI Masahiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
TAKAUE Yoichi
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
HEIKE Yuji
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
NAGASE Kumiko
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
TAKAHASHI Noriko
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
WAKI Fusako
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
AIZAWA Shin
Department of Functional Morphology, Nihon University School of Medicine
-
OMATSU Mutsuko
Clinical Laboratory, National Cancer Center Hospital
-
ONO Makiko
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
SHIBATA Tsuyoshi
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
MIKAMI Yuzuru
Medical Mycology Research Center (MMRC), Chiba University
-
TSUCHIYA Takahide
Department of Hematology and Oncology, Tokai University School of Medicine
-
MINAMI Hironobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Kikuchi M
Department Of Pathology School Of Medicine Fukuoka University
-
NAKAHATA Tatsutoshi
Department of Pediatrics, Kyoto University
-
佐々木 毅
東北大学病院血液免疫科
-
Nakamura Yusuke
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of T
-
BABA Hideo
Department of Surgery, Kyushu Cancer Center
-
KATO Koji
Division of Hematology-Oncology, Children's Medical Center, the Japanese Red Cross Nagoya First Hosp
-
NAGAI Hirokazu
Department of Clinical Research, Nagoya National Hospital
-
KINOSHITA Tomohiro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
YOKOI Takio
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital
-
OHASHI Haruhiko
Clinical Research Center for Blood Disease, National Hospital Organization Nagoya Medical Center
-
SHIKU Hiroshi
Second Department of Internal Medicine, Mie University School of Medicine
-
TOMONAGA Masao
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
Totsune Kazuhito
Department Of Clinical Pharmacology And Therapeutics Tohoku University Graduate School Of Pharmaceut
-
KAWA Keisei
Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Chil
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
Minami Hironobu
名古屋第一赤十字病院
-
Minami Hironobu
National Cancer Center Hospital East
-
UENO Hideki
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
-
OHTSU Atsushi
Gastrointestinal Oncology Division, National Cancer Center Hospital East
-
NISHIWAKI Satoshi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
YASUDA Takahiko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
IMAHASHI Nobuhiko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
NIIMI Keiko
Department of Hematology, Meitetsu Hospital
-
YOKOZAWA Toshiya
Clinical Research Center, National Hospital Organization Nagoya Medical Center
-
OGAWA Hiroyasu
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
UEDA Yasunori
Department of Pediatrics and Department of Hematology/Oncology, Kurashiki Central Hospital
-
ISHIDA Fumihiro
Department of Internal Medicine, Shinshu University School of Medicine
-
OGAWA Hiroshi
Department of Pathology, Seirei Mikatahara General Hospital
-
Nagane Y
Sanai Hospital Iwate Jpn
-
Nagane Yutaka
東京大学医科学研究所ヒトゲノム解析センター
-
Nagane Yutaka
Department Of Urology Sanai Hospital
-
KASAI Masaharu
Department of Hematology, Sapporo Hokuyu Hospital
-
Baba Hideo
熊本大学 医学薬学研究部消化器外科学
-
HANAMURA Akitoshi
Department of Hematology, Gifu Prefectural Tajimi Hospital
-
NAKAGAWA Hidewaki
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University
-
ODA Ichiro
Endoscopic Division, National Cancer Center Hospital
-
Mera Kiyomi
Gastrointestinal Oncology/diagnostic Endoscopy Division National Cancer Center Hospital East
-
Yamaguchi Yuko
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Nakagawa Hidewaki
東京大学医科学研究所ヒトゲノム解析センター ゲノムシークエンス解析分野
-
Nakagawa Hidewaki
Laboratory Of Molecular Medicine Human Genome Center Institute Of Medical Science The University Of
-
Nakagawa H
Osaka Univ. Medical School Osaka
-
USUI Noriko
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
ASAI Osamu
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
OCHIAI Atsushi
Pathology Division, Research Center for Innovative Oncology, National Cancer Center Research at Kash
-
MATSUNO Yoshihiro
Pathology Division, National Cancer Center Hospital
-
Murate T
Nagoya University School Of Health Science
著作論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Pregnancy among long-term survivors of acute leukemia. A second nationwide survey
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- NAD(P)H : quinone oxidoreductase 1 (NQ01) C609T polymorphism and the risk of eight cancers for Japanese
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
- Genotype announcement in a genetic polymorphism study for health checkup examinees at Nagoya University Hospital
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Recovery of Normal Hematopoiesis after Severe Bone Marrow Aplasia Induced by Interferon-α in a Patient with Chronic Myelogenous Leukemia
- Retrospective Study on the Impact of Hepatitis B and Hepatitis C virus Infection on Hematopoietic Stem Cell Transplantation in Japan
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma
- Clinical impact of radiotherapy for locally advanced pancreatic cancer
- Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis
- Hepatocellular apoptosis associated with cytotoxic T/natural killer-cell infiltration in chronic active EBV infection
- Macrophages in Langerhans cell histiocytosis are differentiated toward M2 phenotype : Their possible involvement in pathological processes
- Is ^F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
- ENDOSCOPIC ULTRASOUND-GUIDED CHOLEDOCHODUODENOSTOMY
- Contrast-enhanced endoscopic ultrasonography (CE-EUS) findings in adrenal metastasis from renal cell carcinoma
- Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration
- Regression of rectal mucosa-associated lymphoid tissue (MALT) lymphoma after antibiotic treatments
- Infant juvenile myelomonocytic leukemia (JMML) with rapid infiltration of multiple organs
- Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL)
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- ABO blood group alleles and the risk of pancreatic cancer in a Japanese population
- Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population
- M2 Macrophage/Microglial Cells Induce Activation of Stat3 in Primary Central Nervous System Lymphoma
- Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study